Chengdu Kanghong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 14.8% in First Three Quarters of 2022

Chengdu Kanghong Pharmaceutical Group Co.,Ltd. (成都康弘药业集团股份有限公司) (002773.SZ) reported a net profit of 750 million yuan in the first three quarters of 2022, up 14.8% year-on-year.

Meanwhile, the company posted 2.6 billion yuan in revenue, down 7.5% year-on-year.

At the end of the reporting period, it had 7.6 billion yuan in total assets and 821.9 million yuan in total liabilities, with a liability-to-asset ratio of 10.8%.